Month: March 2025

Oslo, 7 March 2025 – DNO ASA, the Norwegian oil and gas operator, today announced it has reached agreement to acquire 100 percent of the shares of Sval Energi Group AS from HitecVision for a cash consideration of USD 450 million based on an enterprise value of USD 1.6 billion. The Sval Energi assets are complementary to DNO’s North Sea portfolio and will add scale and diversification to solidify the Company’s position as a leading listed European independent oil and gas company. The acquisition will be financed from existing liquidity including available credit facilities. The Company will set in place the optimal capital structure prior to completion. “This is a rare opportunity to acquire a portfolio of high-quality oil and gas assets on the Norwegian Continental Shelf,” said DNO’s Executive Chairman Bijan Mossavar-Rahmani, “and we have...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, JAPAN, HONG KONG, SOUTH KOREA, OR ANY JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Oslo, 7 March 2025 Reference is made to the stock exchange announcement published on 21 January 2025 regarding the launch by Blue Northern BLK Ltd (“Blue Northern” or the “Offeror”) of a recommended voluntary cash tender offer for all issued and outstanding shares (the “Shares”) in Belships ASA (“Belships” or the “Company”) at a price of NOK 20.50 per share (the “Offer”), as further set out in the offer document dated 21 January 2025 (the “Offer Document”). The acceptance period for the Offer will...

Largest safety data set on FcRn blocking demonstrates consistent, favorable safety profile of VYVGART and VYVGART Hytrulo gMG patients on VYVGART achieve rapid, substantial, and sustained efficacy across multiple dosing regimens, supporting individualized treatment approach ADHERE+ oral presentation builds upon evidence of VYVGART Hytrulo driving improved functional ability in CIDPAmsterdam, the Netherlands – March 7, 2025 – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced clinical trial and real-world data for VYVGART® (efgartigimod alfa-fcab) and VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) will be presented at the American Academy of Neurology (AAN) Annual Meeting, taking place in San Diego,...

The new center will be a hub for both Roche and Genentech, bringing together expertise in Cardiovascular, Renal, and Metabolism, as well as for data science and AI specialists to drive innovation in drug discovery and development Roche will be the first to join Harvard’s Enterprise Research Campus in Allston, taking a suite in the first phase of the project’s cutting-edge lab space Starting with a lease of 30’000 square feet, Roche intends to invest over the coming years into a research and development presence with eventually up to 500 employees Roche has long standing partnerships with Harvard University and others in the region and the center will expand Roche’s and Genentech’s presence in the vibrant Boston healthcare ecosystemBasel, March 7, 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY), announced today the launch of the Roche...

Cergy, March 7th 2025 – SPIE, the independent European leader in multi-technical services in the areas of energy and communications, is hosting its 2025 Investor Day today at 9 am CET. At this event, SPIE’s management team will provide an in-depth look at the Group’s strategy and value creation model. Building on its unique positioning in markets that keep evolving and remain firmly driven by the energy transition and the digital transformation, SPIE is poised to deliver lasting growth. Gauthier Louette, Chairman and CEO of SPIE, declared: “Having already reached in 2024 the targets of our 2022-2025 plan, we are entering a new phase of growth and value creation. We are committed to consistently delivering on what makes our business model unique. Our strong positioning as an independent, pure-play leader in multi-technical services across...

At the Annual General Meeting on 31 March 2025, the Supervisory Board of AS Inbank will propose the election of Isabel Margaret Anne Faragalli and Sergei Anikin to the Supervisory Board for a three-year term, effective 1 April 2025. According to Jan Andresoo, Chairman of the Inbank Supervisory Board, the addition of strong finance sector and tech expertise, along with increasing the proportion of independent members, is aimed at supporting Inbank’s journey toward becoming a public company. “As Inbank and the complexity of the business continue to grow, we need to further strengthen our governance structure which is why I’m very excited to welcome Isabel Faragalli and Sergei Anikin to the Supervisory Board. Isabel brings deep expertise in capital markets, while Sergei contributes strong leadership in technology. Together, they will help...

Strategic Investment Strengthens Logistics Pathway to Develop Minim Martap Toward Production PERTH, Australia, March 06, 2025 (GLOBE NEWSWIRE) — Canyon Resources Limited (ASX: CAY) (‘Canyon’ or the ‘Company’) is pleased to announce that the Board of CAMRAIL SA (‘Camrail’) has approved Total Energies Marketing Cameroun SA (‘Total Cameroon’) and Societe d’Exploitation des Bois du Cameroun (‘SEBC’) to enter into two share sale agreements with the Company’s wholly owned in-country subsidiary Camalco Cameroon SA (‘Camalco’). The agreements will see Camalco acquire a strategic 9.1% investment in Camrail as well as secure a position on the Camrail Board upon the completion of the two acquisitions. Camalco acquired a 3.8% equity interest in Camrail from SEBC for an upfront cash consideration of XAF 575,700,000 (approximately A$1.4 million)...